Overview

A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Oral Dose of Midazolam in Healthy Subjects

Status:
Completed

Trial end date:
2018-08-27

Target enrollment:

Participant gender:

Summary

This is a single center, open-label, fixed sequence study to investigate the effect of multiple oral dosing of Inarigivir Soproxil and a single oral dose of Midazolam in Healthy Subjects

Phase:

Phase 1

Details

Lead Sponsor:

F-star Therapeutics, Inc.
Spring Bank Pharmaceuticals, Inc.

Collaborator:

PRA Health Sciences

Treatments:

Midazolam